Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118124945 | 11812494 | 5 | F | 2010 | 20160809 | 20151208 | 20160816 | EXP | PHHY2015GB157421 | SANDOZ | 0.00 | Y | 0.00000 | 20160816 | OT | COUNTRY NOT SPECIFIED | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118124945 | 11812494 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | U | U | 76859 | |||||||||
| 118124945 | 11812494 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | 450 MG | U | U | B1010B08,B00442B01,B104B13 | 0 | 450 | MG | |||||
| 118124945 | 11812494 | 3 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | 600 MG, UNK | U | U | B1010B08,B00442B01,B104B13 | 0 | 600 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118124945 | 11812494 | 1 | Product used for unknown indication |
| 118124945 | 11812494 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118124945 | 11812494 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118124945 | 11812494 | Arthralgia | |
| 118124945 | 11812494 | Bladder irritation | |
| 118124945 | 11812494 | Blood pressure increased | |
| 118124945 | 11812494 | Dizziness | |
| 118124945 | 11812494 | Dry skin | |
| 118124945 | 11812494 | Dysuria | |
| 118124945 | 11812494 | Fall | |
| 118124945 | 11812494 | Fatigue | |
| 118124945 | 11812494 | Feeling abnormal | |
| 118124945 | 11812494 | Gingival pain | |
| 118124945 | 11812494 | Head injury | |
| 118124945 | 11812494 | Hepatic neoplasm | |
| 118124945 | 11812494 | Joint swelling | |
| 118124945 | 11812494 | Lacrimation increased | |
| 118124945 | 11812494 | Local swelling | |
| 118124945 | 11812494 | Musculoskeletal stiffness | |
| 118124945 | 11812494 | Myalgia | |
| 118124945 | 11812494 | Nasal congestion | |
| 118124945 | 11812494 | Neoplasm progression | |
| 118124945 | 11812494 | Neuralgia | |
| 118124945 | 11812494 | Onychoclasis | |
| 118124945 | 11812494 | Pain in extremity | |
| 118124945 | 11812494 | Photophobia | |
| 118124945 | 11812494 | Pruritus | |
| 118124945 | 11812494 | Rhinorrhoea | |
| 118124945 | 11812494 | Sinus pain | |
| 118124945 | 11812494 | Skin abrasion | |
| 118124945 | 11812494 | Trigeminal neuralgia | |
| 118124945 | 11812494 | Urinary retention | |
| 118124945 | 11812494 | Urine flow decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118124945 | 11812494 | 2 | 2010 | 0 |